40
Views
7
CrossRef citations to date
0
Altmetric
Research Article

MK-383 (Tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor

, , , &
Pages 133-140 | Published online: 07 Jul 2009

  • Calvete J J. On the structure and function of platelet integrin alphaIIbbeta3, the fibrinogen receptor. Proc Soc Exp Biol Med 1995; 208: 346-60.
  • Sims P J, Ginsberg M H, Plow E F, Shattil S J. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 1991; 266: 7345-52.
  • Shattil S J. Signaling through platelet integrin alpha lib beta 3: inside-out, outside-in, and sideways. Thromb Haemost 1999; 82: 318-25.
  • Shattil S J, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood 1998; 91: 2645-57.
  • Ruggeri Z M. New insights into the mechanisms of platelet adhesion and aggregation. Semin Hematol 1994; 31: 229-39.
  • Bhatt D L, Topol E J. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. J Am Med Assoc 2000; 284: 1549-58.
  • Sabatine M S, Jang I K. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med 2000; 109: 224-37.
  • Sims P J, Ginsberg M H, Plow E F, Shattil S J. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 1991; 266: 7345-52.
  • Wittig K, Rothe G, Schmitz G. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852. Thromb Haemost 1998; 79: 625-30.
  • Peter K, Schwarz M, Ylanne J, Kohler B, Moser M, Nordt T, et al. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood 1998; 92: 3240-9.
  • Bednar B, Cook J J, Holahan M A, Cunningham M E, Jumes P A, Bednar R A, et al. Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa. Blood 1999; 94: 587-99.
  • Szollosi J, Damjanovich S, Matyus L. Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research. Cytometry 1998; 34: 159-79.
  • Koksch M, Rothe G, Kiefel V, Schmitz G. Fluorescence resonance energy transfer as a new method for the epitope-specific characterization of anti-platelet antibodies. J Immund Methods 1995; 187: 53-67.
  • Furman M I, Benoit S E, Barnard M R, Valeri C R, Borbone M L, Becker R C, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-8.
  • Li N, Goodall A H, Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates. Br J Haematol 1997; 99: 808-6.
  • Hato T, Pampori N, Shattil S J. Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin alphaIIb beta3. J Cell Biol 1998; 141: 1685-95.
  • Gao J, Zoller K E, Ginsberg M H, Brugge J S, Shattil S J. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha lib beta 3. EMBO J 1997; 16: 6414-25.
  • Clark E A, Shattil S J, Ginsberg M H, Bolen J, Brugge J S. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha lIb beta 3. J Biol Chem 1994; 269: 28859-64.
  • Hartwig J H, Kung S, Kovacsovics T, Janmey P A, Cantley L C, Stossel T P, et al. D3 phosphoinositides and outside-in integrin signaling by glycoprotein IIb-IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate. J Biol Chem 1996; 271: 32986-93.
  • Kovacsovics T J, Bachelot C, Toker A, Vlahos C J, Duckworth B, Cantley L C, et al. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem 1995; 270: 11358-66.
  • Jennings L K, Haga J H, Slack S M. Differential expression of a ligand induced binding site (LIBS) by GpIIb/IIIa ligand recognition peptides and parenteral antagonists. Thromb Haemost 2000; 84: 1095-102.
  • Dickfeld T, Ruf A, Pogatsa-Murray G, Müller I, Engelmann B, Taubitz W J, et al. Differential antiplatelet effects of various glycoprotein Iib-IIIa antagonists. Thromb Res 2001; 101: 53-64.
  • Leisner TM, Wencel-Drake J D, Wang W, Lam S C. Bidirectional transmembrane modulation of integrin alphaIIbbeta3 conformations. J Biol Chem 1999: 274: 12945-9.
  • Honda S, Tomiyama Y, Aoki T, Shiraga M, Kurata Y, Seki J, Matsuzawa Y. Association between ligand-induced conformational changes of integrin aIIbß3 and aIIbß3-mediated intracellular Ca2+ signaling. Blood 1998; 92: 3675-83.
  • Cierniewski C S, Byzova T, Papierak M, Haas T A, Niewiarowska J, Zhang L, et al. Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses. J Biol Chem 1999; 274: 16923-32.
  • Hu D D, White C A, Panzer-Knodle S, Page J D, Nicholson N, Smith J W. A new model of dual interacting ligand binding sites on integrin alphaIIbbetaS. J Biol Chem 1999; 274: 4633-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.